483 Bell Pharmaceuticals Apr 2018

483 Bell Pharmaceuticals Apr 2018

Andrew Idzior FDA$119.00 - Available Now

FDA investigators audited the Bell Pharmaceuticals - Belle Plaine, MN, United States facility and issued inspectional observations (via FDA 483) on 06 Apr 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 06 Apr 2018
  • Location: Belle Plaine, United States
  • FEI: 2123499
Add To Cart